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Abstract
Objective: The Canadian Perinatal Network (CPN) maintains an
ongoing national database focused on threatened very preterm
birth. The objective of the network is to facilitate between-hospital
comparisons and other research that will lead to reductions in the
burden of illness associated with very preterm birth.
Methods: Women were included in the database if they were admitted
to a participating tertiary perinatal unit at 22+0 to 28+6 weeks’
gestation with one or more conditions most commonly
responsible for very preterm birth, including spontaneous preterm
labour with contractions, incompetent cervix, prolapsing
membranes, preterm prelabour rupture of membranes,
gestational hypertension, intrauterine growth restriction, or
antepartum hemorrhage. Data were collected by review of
maternal and infant charts, entered directly into standardized

electronic data forms and uploaded to the CPN via a secure
network.
Results: Between 2005 and 2009, the CPN enrolled 2524 women
from 14 hospitals including those with preterm labour and
contractions (27.4%), short cervix without contractions (16.3%),
prolapsing membranes (9.4%), antepartum hemorrhage (26.1%),
and preterm prelabour rupture of membranes (23.0%). The mean
gestational age at enrolment was 25.9 ± 1.9 weeks and the mean
gestation age at delivery was 29.9 ± 5.1 weeks; 57.0% delivered
at < 29 weeks and 75.4% at < 34 weeks. Complication rates
were high and included serious maternal complications (26.7%),
stillbirth (8.2%), neonatal death (16.3%), neonatal intensive care
unit admission (60.7%), and serious neonatal morbidity (35.0%).
Conclusion: This national dataset contains detailed information
about women at risk of very preterm birth. It is available to
clinicians and researchers who are working with one or more
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CPN collaborators and who are interested in studies relating
processes of care to maternal or perinatal outcomes.

Résumé
Objectif : Le Réseau périnatal canadien (RPC) tient une base de
données nationale continue centrée sur l’accouchement très
prématuré appréhendé. L’objectif du réseau est de faciliter les
comparaisons interhôpitaux et la tenue d’autres recherches qui
mèneront à des réductions du fardeau de la maladie associé à
l’accouchement très prématuré.
Méthodes : Les femmes étaient incluses à la base de données
lorsqu’elles étaient admises dans une unité périnatale tertiaire
participante entre 22+0 et 28+6 semaines de gestation en raison
de la présence d’un ou de plusieurs des états pathologiques
les plus couramment à l’origine de l’accouchement très
prématuré (dont le travail préterme spontané s’accompagnant
de contractions, la béance du col utérin, le prolapsus des
membranes, la rupture prématurée des membranes préterme,
l’hypertension gestationnelle, le retard de croissance intra-utérin
ou l’hémorragie antepartum). Les données ont été recueillies au
moyen de l’analyse des dossiers maternels et infantiles, saisies
directement dans des formulaires de données électroniques
standardisés et téléchargées dans le RPC par l’intermédiaire
d’un réseau sécurisé.
Résultats : Entre 2005 et 2009, le RPC a sollicité la participation
de 2 524 femmes issues de 14 hôpitaux, y compris celles qui
présentaient un travail préterme s’accompagnant de contractions
(27,4 %), un col court sans contractions (16,3 %), un prolapsus
des membranes (9,4 %), une hémorragie antepartum (26,1 %) et
la rupture prématurée des membranes préterme (23,0 %). L’âge
gestationnel moyen au moment de l’admission à l’étude était
de 25,9 ± 1,9 semaines et l’âge gestationnel moyen au moment
de l’accouchement était de 29,9 ± 5,1 semaines; 57,0 % ont
accouché à < 29 semaines et 75,4 %, à < 34 semaines. Les taux
de complication étaient élevés et comptaient des complications
maternelles graves (26,7 %), la mortinaissance (8,2 %), le décès
néonatal (16,3 %), l’admission à l’unité néonatale des soins
intensifs (60,7 %) et la morbidité néonatale grave (35,0 %).
Conclusion : Cet ensemble de données nationales renferme des
renseignements détaillés sur les femmes exposées à des risques
de connaître un accouchement très prématuré. Il est mis à la
disposition des cliniciens et des chercheurs qui travaillent avec
un ou plusieurs collaborateurs du RPC et qui s’intéressent aux
études cherchant à établir des liens entre les processus de soins
et les issues maternelles ou périnatales.
J Obstet Gynaecol Can 2011;33(2):111–120

INTRODUCTION

T

he Canadian Perinatal Network is an initiative funded
by the Canadian Institutes for Health Research that
maintains a national database of information collected from
a prospective cohort of women at high risk for very preterm
birth (i.e., between 22+0 and 28+6 weeks’ gestation). This
ongoing initiative was designed to examine how differences
Key Words: Maternal complications, perinatal complications,
quality improvement, variation, preterm labour
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in maternal and perinatal outcomes between tertiary
perinatal units in Canada might be explained by variations in
obstetric and neonatal care practices. Towards this end, the
CPN collects information on adverse maternal, fetal, and
neonatal outcomes, obstetric and neonatal care practices,
and maternal and pregnancy characteristics among women
with threatened very preterm birth.
Although maternal mortality is rare in Canada (with a
maternal mortality ratio of 5.5 deaths per 100 000 live
births in 2002 to 2004),1 serious maternal morbidity remains
a concern, especially among women with threatened very
preterm birth. Maternal complications may be related to
underlying disease (e.g., the 20-fold increased risk of maternal
mortality/serious morbidity associated with early gestational
hypertension and proteinuria), direct complications of the
obstetric problem (e.g., chorioamnionitis associated with
preterm prelabour rupture of membranes), or treatment
(e.g., thromboembolism associated with bed rest prescribed
for fetal growth restriction).2,3 To date, severe maternal
morbidity associated with very preterm delivery has not
been adequately studied.
One major obstacle to a pan-Canadian study of maternal
and infant complications associated with threatened very
preterm birth is the absence of detailed information on this
condition. Although many current regional or provincial
perinatal health programs collect information on perinatal
issues, these databases have been designed primarily for
perinatal surveillance. The programs do not cover the
entire country, and definitions have not been harmonized.4
Most importantly, there is insufficient obstetric practice
information for determining what aspects of care result in
the best outcomes for mothers and babies.
We describe here the baseline characteristics and outcomes
for the first 2524 women enrolled in the CPN. Our
objective is to generate interest in this database, which is
available to clinicians and investigators who work with a
CPN collaborator and who are interested in conditionspecific analyses of the relationship between processes of
care and maternal or perinatal outcomes.
METHODS

The CPN was initially funded by the Canadian Institutes
for Health Research in March 2005, to focus on the optimal
management of threatened very preterm birth at 22+0 to
28+6 weeks’ gestation. Data collection began in August
2005, and by July 31, 2009, the CPN database contained
data from 14 of Canada’s 23 tertiary perinatal units. Three
additional sites are poised to start data collection. All sites
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completed a questionnaire about resources and practices
at their centre. The Research Ethics Committee at each
participating centre reviewed and approved the CPN as
a quality assurance project that did not require individual
informed consent. Experience with this process has been
detailed elsewhere.5
Women had data from their pregnancy submitted to the CPN
if they were admitted to a participating tertiary perinatal
unit at 22+0 to 28+6 weeks’ gestation with one or more
of the following “indicator” conditions most commonly
responsible for very preterm birth: spontaneous PTL with
contractions, incompetent cervix, prolapsing membranes,
PPROM, gestational hypertension, IUGR, or antepartum
hemorrhage. All hospitals used standard definitions for the
indicator conditions and maternal and perinatal outcomes
identified (Appendix 1). If a woman contributed data from
more than one pregnancy to the CPN, we included only the
data from the first pregnancy in this analysis. Women seen
in the triage area or obstetrical day unit of a participating
hospital and subsequently discharged were not enrolled in
the CPN. For women admitted to hospital but subsequently
discharged before delivery, all subsequent re-admissions
were recorded in the CPN, up to and including delivery. If
the patient was transferred to another facility, the woman
and her baby or babies were considered lost to follow-up if
delivery information could not be obtained.
Each participating centre identified its own data abstractor.
The abstractor received a CPN Working Protocol and
detailed CPN Database Manual (v2.0). A two-day training
seminar was held in Vancouver, BC in April 2006, prior to
data collection. A day-long site visit was made to each active
centre by the central CPN Coordinator, who also offered
ongoing support for questions that arose after training and
site visits. Quarterly newsletters addressed changes and
frequently asked questions.
Data abstractors identified potentially eligible women
either from the delivery suite and antenatal ward logbooks

ABBREVIATIONS
APH

antepartum hemorrhage

CNN

Canadian Neonatal Network

CPN

Canadian Perinatal Network

IQR 		

interquartile range

IUGR

intrauterine fetal growth restriction

PPROM preterm prelabour rupture of membranes
PTL 		

preterm labour

(9 centres) or from Canadian Institute for Health
Information coded data searches using the gestational age
at admission (5 centres). Regardless, the data abstractor
reviewed the maternal chart and verified whether the
patient met CPN inclusion criteria. Data were collected by
review of the maternal and infant records, from hospital
admission at eligibility until final discharge from hospital
after delivery (and if relevant, including subsequent
postpartum re-admissions). Maternal information collected
included maternal characteristics, obstetrical history, past
medical history, risk factors and screening in the current
pregnancy, details of the hospital admission, maternal
(and fetal) surveillance, maternal interventions including
pharmacotherapy, maternal outcomes, and delivery data.
Data related to neonatal outcomes were obtained from
two sources. For babies admitted to a neonatal intensive
care unit, probabilistic linkage was used to obtain data
from the Canadian Neonatal Network, a sister network of
CPN in the Maternal-Infant Care Network (MiCare). For
babies admitted to NICU for < 24 hours, or not admitted
to NICU, data were obtained directly from the neonatal
hospital record. When a woman did not deliver at the CPN
site at which she was first enrolled, every effort was made
to obtain delivery and neonatal information from available
sources.
Data were entered directly into the standardized electronic
data collection forms and uploaded to CPN from each
active site through a secure hospital network. These
electronic data collection forms include features such as
sequential assignment of case numbers, error checking
for incomplete and abnormal values, daily back-up, and
monthly data transfer to the Coordinating Centre by a
secure network after removal of patient identifiers.
For this analysis, descriptive statistics were computed for the
frequency of specific CPN indicator conditions, maternal
characteristics and past medical and surgical history,
characteristics of the current pregnancy, and maternal and
perinatal outcomes. The unit of analysis was the pregnancy.
Missing data were identified for each outcome. Categorical
data are presented as n (%) and continuous data as mean
(SD) or median (IQR), as appropriate. Chi-square tests
were used to compare proportions, with a two-sided P <
0.05 considered statistically significant.
RESULTS

Between August 1, 2005 and July 31, 2009, data from 2524
women (2536 pregnancies) in 14 active tertiary perinatal
hospitals across Canada were submitted to the CPN. The
details of women (83.6%) and infants (83.5%) followed
FEBRUARY JOGC FÉVRIER 2011 l 113
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Cases entered into the CPN database and lost to follow-up before and after delivery

Table 1. Indicator conditions for the first 2524 women enrolled in the Canadian Perinatal Network
Total (n = 2524)

Women followed to delivery
(n = 2109)

Women lost to follow-up
(n = 415 )

P (followed up vs.
lost to follow-up)

Indicator condition for
enrolment*

Women
n (%)†

Condition
severe, n (%)

Women
n (%)†

Condition
severe,
n (%)*

Women
n (%)†

Condition
severe, n (%)

Women †

Condition
severe

PTL with contractions

692 (27.4)

273 (39.5)

570 (27.0)

260 (45.6)

122 (29.4)

13 (10.7)

0.34

< 0.001

APH

659 (26.1)

57 (8.7)

540 (25.6)

51 (9.4)

119 (28.7)

6 (5.0)

0.20

0.15

PPROM

580 (23.0)

72 (12.4)

516 (24.5)

65 (12.6)

64 (15.4)

7 (10.9)

< 0.001

0.84

Short cervix (no contractions)

412 (16.3)

153 (37.1)

321 (15.2)

127 (39.6)

91 (21.9)

26 (28.6)

0.001

0.07

Gestational hypertension

276 (10.9)

197 (71.4)

262 (12.4)

192 (73.3)

14 (3.4)

5 (35.7)

< 0.001

0.005

Prolapsing membranes

236 (9.4)

155 (65.7)

206 (9.8)

143 (69.4)

30 (7.2)

12 (40.0)

0.12

0.003

Idiopathic IUGR

146 (5.8)

90 (61.6)

128 (6.1)

78 (60.9)

18 (4.3)

12 (66.7)

0.21

0.80

*Definitions of the indicator conditions for enrolment in CPN are provided in Appendix 1.
†The indicator conditions are not mutually exclusive.

up from enrolment to final hospital discharge are shown
in the Figure. The “indicator” conditions at enrolment in
the CPN are shown in Table 1. Overall, 76.5% of women
had either PTL with contractions, APH, or PPROM. Six
hundred fourteen women (24.3%) had more than one
indicator condition at enrolment, usually PTL with either
PPROM (4.8%) or APH (3.5%). Women who were followed
to delivery more often had severe PTL, PPROM, severe
gestational hypertension, or severe prolapsing membranes
(see Appendix 1 for definitions regarding severity). Women
who were lost to follow-up before delivery were more likely
to have a short cervix without contractions.
The maternal characteristics and pregnancy history of the
women enrolled in the database are shown in Table 2. The
114 l FEBRUARY JOGC FÉVRIER 2011

average maternal age was 30.6 years and approximately one
half were parous. A substantial amount of information
related to ethnicity, BMI, and prenatal care was missing;
among those with information on these determinants,
most were Caucasian (67%), had a normal BMI, and had
had four or more prenatal care visits. A minority of women
(< 5%) had a pre-existing medical condition, including
diabetes or hypertension. Among parous women, previous
Caesarean section (27.3%) and previous preterm birth at
< 37 weeks (32.4%) or < 34 weeks (20.6%) were common
antecedents. Most women did not smoke or use alcohol
or illicit drugs during pregnancy. Women were enrolled in
the CPN at a mean gestational age of 25.9 (SD 1.9) weeks
and a median gestational age of 26.1 (IQR 24.3 to 27.6)
weeks. Women who were followed to delivery were slightly
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Table 2. Maternal characteristics and pregnancy history of the initial 2524 women enrolled in the Canadian Perinatal Network
Total N = 2524
Maternal age at EDD, year

30.6 ± 5.9

Women followed to delivery (n = 2109) Women lost to follow-up (n = 415)
30.71 ± 6.0

29.94 ± 5.5

Ethnicity, n (%)

0.02
0.60

Caucasian

1148 (67.0)

960 (66.3)

188 (70.4)

Asian or Indo-Canadian

296 (17.3)

251 (17.4)

45 (16.9)

Afro-Canadian

109 (6.4)

97 (6.7)

12 (4.5)

Native Canadian

89 (5.2)

77 (5.3)

12 (4.5)

Other

72 (4.2)

62 (4.3)

10 (3.8)

Missing, n (%)*

P

810 (32.1)

662 (31.4)

148 (35.7)

67 079 ± 15 978

67 230 ± 16 130

66 293 ± 15 158

78 (3.1)

58 (2.8)

20 (4.8)

Underweight (BMI < 20)

257 (18.7)

209 (18.0)

48 (21.9)

0.19

Normal weight (BMI 20–24)

571 (41.4)

469 (40.5)

102 (46.8)

0.10

Overweight (BMI 25–29)

293 (21.3)

259 (22.4)

34 (15.5)

0.02

Obese (BMI ≥ 30)

257 (18.7)

222 (19.2)

35 (16.0)

0.30

1146 (45.4)

950 (45.1)

196 (47.2)

106 (4.2)

96 (4.5)

10 (2.4)

Diabetes mellitus

44 (1.7)

36 (1.7)

8 (1.9)

0.69

Venous thromboembolism

14 (0.60)

12 (0.6)

2 (0.5)

> 0.99

Uterine structural abnormalities‡

98 (3.9)

87 (4.1)

11 (2.7)

0.17

Other§

87 (3.5)

76 (3.6)

11 (2.7)

0.38

395 (15.7)

391 (18.5)

4 (1.0)

< 0.001

Nulliparity

1240 (49.1)

1,054 (50.0)

186 (44.8)

0.06

Parity of 1

732 (29.0)

608 (28.8)

124 (29.88)

0.68

Parity ≥ 2

552 (21.9)

447 (21.2)

105 (25.3)

0.07

n = 1284

n = 1055

n = 229

Previous Caesarean section, n (%)

351 (27.3)

294 (27.9)

57 (24.9)

0.41

Previous preterm birth, n (%)
< 37 weeks

416 (32.4)

342 (32.4)

74 (32.3)

> 0.99

265 (20.6)

215 (20.4)

50 (21.8)

0.65

445 (17.8)

365 (17.5)

80 (19.6)

0.32

25 (1.0)

18 (0.9)

7 (1.7)

119 (4.8)

51 (2.4)

5 (1.2)

31 (1.2)

20 (1.0)

11 (2.7)

83 (3.3)

73 (3.5)

10 (2.5)

28 (1.11)

18 (0.85)

10 (2.41)

Socioeconomic status (income, $)†

Missing
Pre-pregnancy BMI (kg/m2), n (%)

Missing

0.37
0.04

Pre-existing medical conditions, n (%)

Pre-existing hypertension

Multiple pregnancy, n (%)

0.05

Parity, n (%)

Parous women

< 34 weeks
Smoking during pregnancy, n (%)

Missing
Alcohol use during pregnancy, n (%)

Missing
Illicit drug use during pregnancy, n (%)

Missing

0.20
0.36

Prenatal care, n (%)

≤ 4 visits

461 (26.85)

457 (27.04)

4 (14.81)

0.19

> 4 visits

1213 (70.65)

1194 (70.65)

19 (70.37)

> 0.99

807 (31.97)

419 (19.87)

388 (93.49)

Missing
Gestational age at enrolment, week
Mean (SD)
Median (IQR)

25.9 ± 1.9

25.9 ± 1.93

26.1 ± 1.8

26.1 (24.3–27.6)

26.1 (24.3–27.6)

26.3 (24.7–27.6)

0.05

EDD: estimated date of delivery.
*Missing data are indicated for each applicable variable. If no missing data are indicated, there were none.
†Expressed as median neighbourhood income levels, derived from postal codes and census enumerator data obtained from Statistics Canada.
‡Uterine structural abnormalities includes bicornuate uterus (40), didelphic uterus (4), leiomyomas (37), unicornuate uterus (5), and other (14).
§Includes thrombophilia (30), hepatitis B (13), hepatitis C (13), HIV (2), and genital herpes (33)
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Table 3. General pregnancy and maternal outcomes
for women followed to delivery in the Canadian
Perinatal Network
Total n = 2109
Gestational age at delivery, week, Mean (SD)

Median (IQR)
Birth at ≥ 37 weeks, n (%)

29.9 (5.1)
28.4 (26.1–33.6)
304 (14.3)

Preterm birth, weeks, n (%)

< 37

1798 (85.3)

< 34

1591 (75.4)

< 29

1197 (56.8)

Maternal outcomes, n (%)

Missing*

1 (0.05)

Admission per woman

1 (1, 2)

Gestational hypertension developed after
enrolment, n (%)

150 (7.1)

Placental abruption developed after
enrolment, n (%)

88 (4.2)

One or more serious maternal
complications, n (%)

562 (26.7)

Death

1 (0.05)

Receipt of blood products

86 (4.1)

Admission to intensive care unit†

67 (3.2)

Chorioamnionitis

405 (19.6)

Sepsis/endometritis

24 (1.1)

Other‡

72 (3.4)

*Missing data are indicated for each applicable variable. If no missing data
are indicated, then there were none.
†Intensive care refers to a full-service adult intensive care unit, and not an
intermediate-care adult area of the hospital (e.g., “high dependency unit”).
‡Other complications included central nervous system: eclampsia (5), stroke
(1), neurological event (1); respiratory: intubation (6), non-invasive ventilation
(4), pulmonary edema (21), oxygen requirement (7); cardiovascular: use
of three parenteral antihypertensives (7), positive inotropic support (1),
myocardial ischemia/infarction (1); hematological: hysterectomy (10), uterine
artery embolization (2), thromboembolism(6); hepatic/gastrointestinal: hepatic
failure (10); renal: acute renal failure (5); other (16).

older, were enrolled at a slightly earlier gestational age, were
more likely to have a multiple pregnancy, and were more
likely to have been overweight pre-pregnancy. The median
latency (pregnancy prolongation from enrolment) was 10
days (IQR 2 to 51).
Pregnancy and maternal outcomes are shown in Table 3.
The median gestational age at delivery was 28.4 weeks.
After a median of one admission, 57.0% of women
delivered at < 29 weeks, 75.8% at < 34 weeks, and 85.7%
at < 37 weeks. A minority of women developed gestational
hypertension (7.1%) or APH (4.2%) following admission.
There was one maternal death after a late presentation
with PPROM and sepsis; this patient delivered on the day
of hospital admission, and, despite treatment with broad
116 l FEBRUARY JOGC FÉVRIER 2011

spectrum antibiotics, she was admitted to the ICU on the
following day. The baby spent 81 days in the NICU and
suffered multiple complications, including retinopathy of
prematurity and hypoxic-ischemic encephalopathy. One
or more serious maternal complications occurred in 562
(26.7%) women. The most common of these complications
was chorioamnionitis (n = 405), 53.9% of which occurred
among women with PPROM.
The perinatal outcomes are shown in Table 4. Infant data
were available for 1761 women (83.5%) with 2086 babies.
The pregnancy outcomes of stillbirth (8.2%) and neonatal
death (16.3%) were associated with a congenital anomaly
in 13/145 (9.0%) and 43/263 (16.4%) cases, respectively.
Of the 239 pregnancies (329 babies) with a congenital
anomaly, 79.9% were considered major. Most babies were
appropriately grown for gestational age. Admission to
NICU occurred for the babies of 60.7% of pregnancies,
and of these 223/1069 (20.9%) had a congenital anomaly.
Most babies admitted to NICU stayed for at least one week.
Serious neonatal morbidities occurred in 566 (35.0%) of
live births.
DISCUSSION

From August 2005 to July 2009, the CPN assembled
information on a cohort of 2524 women with threatened
preterm delivery at 22+0 to 28+6 weeks. The conditions
responsible for threatened very preterm delivery included
PTL with contractions (27.4%), short cervix without
contractions (16.3%), prolapsing membranes (9.4%),
PPROM (23.0%), APH (26.1%), gestational hypertension
(10.9%), and IUGR (5.8%). Approximately one half of
these women delivered before 29 weeks, with another
25% delivering at 29 to 33+6 weeks, and 15% delivering
at 34+0 to 36+6 weeks. Not surprisingly, the incidence of
perinatal complications in this cohort was high. The mean
gestational age at delivery was 29.9 ± 5.1 weeks with an
associated perinatal mortality of 24.5%. Admission to
NICU was required for 60.7% of babies, 96.3% of whom
stayed for at least one week and 35.0% of whom had one
or more serious neonatal complications. More than one
quarter of enrolled women (26.7%) suffered one or more
serious maternal complications, usually chorioamnionitis.
There was one maternal death from sepsis.
The primary strength of the CPN is its national scope and
the size of the cohort assembled.
As the CPN is a national network recruiting across Canada
using continuous quality improvement methodology,
concerns about generalizability are limited. Women with
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threatened very preterm birth at < 29 weeks usually present
at, or are transferred to, a tertiary perinatal unit. Using this
information, Canadian tertiary centres will now be able
to benchmark their performance against that of their
Canadian peers, an exercise that has proved to be valuable
in international pregnancy hypertension benchmarking.6,7
Misclassification arising from data abstraction is unlikely, as
we implemented abstractor training, used standard codebooks, and randomly re-abstracted charts for checking.
Admission bias was minimized by Canada’s public health
care system, in which all women at risk of delivering < 29
weeks’ gestation are admitted to tertiary level units prior
to delivery. The numbers of women available for studies
of specific conditions varied considerably, and small
numbers may preclude meaningful analysis of some issues.
However, enrolment in CPN is ongoing and we anticipate
a substantial increase in cohort size.
An additional important strength of the CPN is our linkage
with the successful national Canadian Neonatal Network8
and the new Canadian Neonatal Follow-up Network, which
will track infants born at < 29 weeks up to 36 months of
age, as part of the MiCare Network. Since 2005, the CNN
has generated important information necessary for making
improvements in NICU management.8–10 Preliminary
analysis of maternal information in the CNN has suggested
that, for pregnancies complicated by hypertension, betweencentre variations in obstetric practice were associated with
variations in neonatal survival, after correction for NICU
practice and antenatal corticosteroid use.11 Further analyses
will help identify the practices associated with improved
maternal and neonatal outcomes.
The major limitation to this study was loss to followup. Maternal loss to follow-up before delivery was
approximately 20%. Although there was no a priori reason
to suspect systematic reasons for the losses to followup, women who have been followed up appear to be at
a higher risk of very preterm birth. The primary cause
of missing data has been the quality of antenatal records
(with information missing on specific determinants such as
pre-pregnancy weight) and, for women lost to follow-up,
subsequent delivery closer to home and outside a tertiary
perinatal unit. For neonatal outcomes, missing data arose
because CNN data are updated centrally on an annual basis,
and a reduction in missing information is anticipated once
the year-end process is completed. An additional strength
of the CPN is that information is captured for stillbirths
and infants who die either before admission to the
NICU or within 24 hours of admission.There are several
existing regional or provincial reproductive care programs

Table 4. Perinatal outcomes among following enrolment
in the Canadian Perinatal Network
Women followed to delivery with infant
outcomes

n = 1761

Infants

n = 2086

n (%)
Perinatal mortality

Stillbirth

145/1761 (8.2)

Neonatal death

263/1616 (16.3)

Congenital anomalies

239/1759 (13.6)

Missing

2/1761 (0.1)

SGA infant

< 10th centile

278/1719 (16.2)

< 3rd centile

108/1719 (6.3)

Missing

42/1761 (2.4)

NICU admission

1069/1761 (60.7)

Stay ≥ 24 hr

1062/1069 (99.4)

Stay ≥ 48 hr

1041/1069 (97.4)

Stay ≥ 7 d

1029/1069 (96.3)

Serious neonatal morbidities*

Bronchopulmonary dysplasia*
Missing

134/1616 (8.29)

Retinopathy of prematurity*
Missing

62/1128 (5.5)
330/1616 (20.42)

Severe brain injury*

117/1417 (8.26)

Missing

199/1616 (12.31)

Necrotizing enterocolitis

91/1606 (5.67)

Missing

10/1616 (0.62)

Sepsis

239/1614 (14.81)

Missing

2/1616 (0.12)

Hypoxic-ischemic encephalopathy*
Missing

566/1616 (35.0),
334/1390 (24.03)

0/638 (0)
7/1616 (0.43)

*Denominator reflects the number of babies for which this outcome is
relevant. Please see Appendix 1 for the definition of each specific morbidity.
The denominator for one or more serious neonatal morbidities was live births.
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that have perinatal surveillance databases.4 However,
collectively, these programs do not cover the country and
most focus their data collection on demographics, past
obstetrical history, maternal lifestyle (e.g., smoking), labour
and delivery, and basic neonatal outcomes, with little
information about interventions.4 For example, only two
programs collect specific information about magnesium
sulphate use, although this is the ideal therapy and an
auditable standard for the management of women with
severe preeclampsia or eclampsia. This difference in focus
between the existing population-based perinatal database
and the CPN database also highlights another facet of
the processes required for monitoring maternal health.
Whereas population-based perinatal databases may be ideal
for identifying temporal or regional disparities in maternal
health, detailed investigation of identified disparities may
require information on interventions and processes of care
that the CPN collects. For example, although postpartum
hemorrhage was recognized to be increasing in Canada
in 2003, 12,13 the reasons for the increase have yet to
be elucidated.
In conclusion, the Canadian Perinatal Network has
successfully created an infrastructure for collecting
information related to threatened very preterm birth from
tertiary perinatal hospitals in Canada. The data collected
will enable an examination of obstetric practice, and
practices associated with good outcomes can be identified,
widely implemented, and audited through the CPN. The
CPN will be able to address issues as diverse as the role of
bed rest as an intervention for high risk pregnancies and
specific antibiotic regimens used in the management of
PPROM.14 The CPN dataset is open to CPN investigators
and clinicians or investigators who are working with a CPN
Collaborator15 and who are interested in condition-specific
analyses relating processes of care to maternal or perinatal
outcomes.
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Appendix 1. Canadian Perinatal Network definitions (May 2008 manual; www.cpn-rpc.org)
Indicators/ Outcomes

Definitions

“Severe” definition

Preterm labour with contractions

Regular contractions every 5 minutes or more frequently, with
documented cervical change. Gestational age on the date of
condition onset must be less than 37+0 weeks.

Regular contractions, with cervix
< 0.5 cm in length and ≥ 2 cm dilated.

Short cervix without contractions

Incompetent cervix or cervical shortening (to less than
2.0 cm; by endovaginal ultrasound examination) without
regular contractions (i.e., occurring every 5 minutes
or more frequently).

Short cervix without regular
contractions: by endovaginal
ultrasound, cervical length < 1.0 cm.

Prolapsing membranes without
contractions

Dilated cervix or prolapsing membranes at or beyond the external
os as visualized on speculum examination, or any cervical
dilatation of external os by endovaginal ultrasound examination,
without regular contractions (i.e., occurring every
5 minutes or more frequently).

Dilated cervix ≥ 2 cm or
“hour-glassing” (i.e., membranes
beyond external cervical os).

PPROM

Prelabour rupture of membranes confirmed by positive ferning
and/or pooling of amniotic fluid. Prelabour means prior to onset
of regular contractions (i.e., occurring every 5 minutes or more
frequently). Gestational age on the date of condition onset must be
less than 37+0 weeks.

PPROM prior to 22 weeks.

Idiopathic IUGR

Ultrasonographically determined abdominal circumference less
than the 10th percentile by local definitions (e.g., provincial data,
Jeanty chart), without a recognized cause other than gestational
hypertension. Cases with recognized chromosomal abnormality,
twin-to-twin transfusion, etc. were not eligible. For multiples, only
one fetus must have IUGR.

Abdominal circumference (AC)
< 3rd centile.

Gestational hypertension

Systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood
pressure (DBP) ≥ 90 mmHg, twice, at least 4 hours apart,
developing after 20 weeks’ gestation.

Gestational hypertension with
proteinuria and one or more adverse
conditions:
• maternal signs: BP of
170/110 mmHg or more, platelets
< 100 000, urine output < 500 mL/d,
pulmonary edema, elevated liver
enzymes (AST or ALT ≥ 70 IU/L)
• maternal symptoms: severe nausea
and vomiting, frontal headache,
visual disturbances, persistent
abdominal pain in right upper quadrant, chest pain or shortness
of breath, suspected placental
abruption, HELLP syndrome
(HELLP is defined as LDH ≥ 600 IU/L,
AST or ALT ≥ 70 IU/L and platelets
< 150 × 106/L)
• fetal signs: intrauterine growth
restriction (< 10th centile by local
criteria), oligohydramnios, or absent/
reversed umbilical artery end diastolic
flow by Doppler velocimetry

APH

Greater than 15 mL of vaginal bleeding prior to the onset of labour.
15 mL of blood was considered to be equivalent to a blood spot of
approximately 2.5 cm in diameter (a Loonie coin). The bleeding did
not have to occur all at once.

Requiring transfusion of any blood
product, within 6 hours of admission,
antenatally or postnatally.

Continued
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Appendix 1. Continued. Canadian Perinatal Network definitions (May 2008 manual; www.cpn-rpc.org)
Definitions

Indicators/ Outcomes
Serious maternal complications

Maternal death, or major organ system dysfunction
(e.g., stroke), transfusion of at least one blood product
during admission, or admission to adult intensive care unit or highdependency obstetrical unit, or diagnosis of suspected or confirmed
chorioamnionitis

Gestational age at delivery

Age in weeks from the best estimate of last menstrual period (LMP)
to the neonate’s date of birth (DOB); calculation based on LMP,
estimated date of delivery (EDD), and actual DOB

Neonatal death

Death within the first 28 days of life or prior to discharge home.

Birth weight

Weight in grams as recorded by the birth hospital or
weight/best estimate within the first 24 hours of life when
unavailable at birth.

Broncho-pulmonary dysplasia

Supplemental oxygen required at 36 weeks corrected
post-gestational age in babies born at ≤ 32 weeks’
gestational age.

Retinopathy of prematurity

Stage 3, 4, or 5 in one or both eyes (examined if birthweight is
< 1500 g or gestational age at birth is < 32 weeks).

Severe brain injury

Intraventricular hemorrhage grade III or IV, ventricular enlargement
with or without germinal matrix or intraventricular hemorrhage,
parenchymal echodensities, lucencies in the white or grey matter,
periventricular leukomalacia, evidence of diffuse brain lesions in the
white matter, or multiple cysts in the white matter on ultrasound.

Necrotizing enterocolitis

Pneumatosis intestinalis (air in the bowel wall or portal/
hepatic air), diagnosed by X-ray, at surgery, or at autopsy.

Sepsis

One or more positive cultures of blood or cerebrospinal fluid.

Hypoxic-ischemic
encephalopathy

Ischemic encephalopathy according to the definition of Sarnat
(stages 2 and 3). This diagnosis was applied only to infants > 2000 g
or ≥ 35 weeks gestational age at birth with both history of a perinatal event consistent with injury (e.g., fetal distress, low Apgar, or
need for resuscitation) and an abnormal neurological examination
over the first 2 to 3 days of life. Alternatively, the diagnosis could
be made from the neonatal intensive care discharge summary if it
indicated one of the following: hypoxic-ischemic encephalopathy,
ischemic encephalopathy, asphyxia, birth asphyxia, or perinatal
asphyxia.

Appendix 2. Additional Canadian Perinatal Network Members
Member

Centre

C Burym

St. Boniface General Hospital & Winnipeg Health Science Centre, Winnipeg MB

G Carson

Regina General Hospital, Regina SK

J Dansereau

Royal Victoria Hospital, Victoria BC

R Gratton

St. Joseph’s Health Centre, London ON

S McDonald

McMaster University Health Centre, Hamilton ON

F Olatunbosun

Royal University Hospital, Saskatoon SK

J-P Pasquier

Université de Sherbrooke, Sherbrooke QC
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